| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/07/2001 | EP1073463A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 02/07/2001 | EP1073459A1 Compositions and methods for tolerization in immune complex-mediated disease progression |
| 02/07/2001 | EP1073456A1 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 02/07/2001 | EP1073455A1 Compositions and methods for extending the action of clostridial neurotoxin |
| 02/07/2001 | EP1073454A1 Methods for treating hot flashes and gynaecomastia |
| 02/07/2001 | EP1073453A1 Methods to increase white blood cell survival after chemotherapy |
| 02/07/2001 | EP1073452A2 Method for treating cytokine mediated hepatic injury |
| 02/07/2001 | EP1073451A2 Method for treating ischemia |
| 02/07/2001 | EP1073450A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| 02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 02/07/2001 | EP1073448A1 Fertility improving composition and application thereof |
| 02/07/2001 | EP1073447A1 N1-modified glycopeptides |
| 02/07/2001 | EP1073444A1 A food composition and method of using same |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073427A1 Periadventitial delivery device |
| 02/07/2001 | EP1073426A1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
| 02/07/2001 | EP1073421A1 Stabilized protein crystals, formulations containing them and methods of making them |
| 02/07/2001 | EP1073416A1 Use of inhaled no as anti-inflammatory agent |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1033997A4 Method of mobilizing hematopoietic stem cells |
| 02/07/2001 | EP0943096A4 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 02/07/2001 | EP0720621B1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/07/2001 | EP0559769B1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 02/07/2001 | EP0462207B1 T-pa mutants resistant to inhibition by their cognate inhibitors |
| 02/07/2001 | CN1283231A Moldified vitamin K-dependent polypeptides |
| 02/07/2001 | CN1283230A Desaturated enzyme |
| 02/07/2001 | CN1283228A Polypeptide, their production method and use |
| 02/07/2001 | CN1283201A K receptor opioid peptides |
| 02/07/2001 | CN1283188A Bisulfate salt of HIV protease inhibitor |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283120A CD8 as inhibitor of cellular immune system |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283107A Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates |
| 02/07/2001 | CN1283082A Carbohydrate oxidase and use thereof in baking |
| 02/07/2001 | CN1282612A Antituberculotic aerosol composition and its preparing process |
| 02/06/2001 | US6184374 Targeted cytotoxic anthracycline analogs |
| 02/06/2001 | US6184372 Preferential nucleotide sequences for the reduction of expression of messenger ribonucleic acid sequences; for treatment of leukemia and aquired inmmunodeficiency syndrome |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184369 Anti-viral guanosine-rich oligonucleotides |
| 02/06/2001 | US6184359 Humanized monoclonal antibody which preferentially binds lymphocyte polypeptide; for treatment of toxicity in tumor therapy; for the treatment and prevention of gastrointestinal and viral diseases |
| 02/06/2001 | US6184358 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor |
| 02/06/2001 | US6184357 Antibody which binds a preferential polypeptide; for the diagnosis, prevention and treatment of prostate cancer and hyperplasia |
| 02/06/2001 | US6184356 Globin protein; for amplifying oxygen carrying capacity of a blood substitute |
| 02/06/2001 | US6184354 Peptides of human macrophage colony stimulating factor binding protein; for the detection of modulators of macrophage colony stimulating factor |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184351 Artificial brain protein; for the treatment of alzheimer's and parkinson's disease |
| 02/06/2001 | US6184346 Peptide of defined amino acid sequence which inhibits elastase and subtilisin; use as drug because of low molecular weight |
| 02/06/2001 | US6184343 Fetal globin inducing factor |
| 02/06/2001 | US6184342 Amino acid sequences preferential for the modulation of granulocytes migratatory response; wound healing agents |
| 02/06/2001 | US6184248 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184227 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184212 Antisense modulation of human mdm2 expression |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis |
| 02/06/2001 | US6184209 Diabetes treatment |
| 02/06/2001 | US6184208 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 02/06/2001 | US6184207 A peptide including specified piperidine-containing group, having an n-terminal hydrophobic residue and optionally an amidated c-terminal of specified end groups; treating multiple sclerosis or rheumatoid arthritis |
| 02/06/2001 | US6184206 Administering a compound which dissociates fibrinogen bound to a first site on platelet glycoprotein iib-iiia, by binding to a second interacting site of the platelet glycoprotein, disaggregating the platelet thrombus |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184204 Peptides suitable for use in antigen specific immunosuppressive therapy |
| 02/06/2001 | US6184203 Low molecular weight gtp-binding proteins (lmwg); inhibiting inflammation in an individual by administering a peptide nadph oxidase inhibitor, which inhibits nadph oxidase in a cell-free assay of given content including a rac protein |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184201 Of given amino acid sequence; use in treating disorders of the small bowel |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/06/2001 | US6184199 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 02/06/2001 | US6184035 Modulation of cellular differentiation in bone associated tissues; culturing muscles tissues under preferential oxygen environment and monitoring development |
| 02/06/2001 | US6184032 Identification of genes encoding cell surface antigens using CREF-Trans 6 cells |
| 02/06/2001 | US6184025 Nucleotide sequences for the detection and diagnosis of viral diseases |
| 02/06/2001 | US6184023 Chondroitinase, process for preparing the same, and pharmaceutical composition comprising the same |
| 02/06/2001 | US6184013 Antibody for reducing concentration of drug in patient |
| 02/06/2001 | US6183991 Nucleotide and amino acid sequence; recombinant production of polypeptide; enhancing viability of cryopreserved sperm, sperm motility, and fertilization in assisted reproduction; contraceptives |
| 02/06/2001 | US6183987 Transfecting insect cell with nucleic acids encoding subunits of hormone where one of the nucleic acids contains a sequence having destabilizing effect on untranslated region of messenger rna, culturing, and recovering |
| 02/06/2001 | US6183976 Isolated polypeptide of defined amino acid sequence having immunogenic portion of babesia microti antigen; vaccines; immunoassay detection |
| 02/06/2001 | US6183971 Human betacellulin-specific antibodies and uses thereof |
| 02/06/2001 | US6183964 Method for identifying suppressor mutations for common p53 cancer mutations |
| 02/06/2001 | US6183961 Nucleotide and amino acid sequences of human cdc5 gene; diagnosis; detection of gene in samples; antisense agents for gene expression inhibition; antiproliferative agents |
| 02/06/2001 | US6183959 Identifying nucleic acid catalyst which modifies a biological system by introducing random library of catalysts into system then determining sequence of portion of substrate binding domain from system which has been modified |
| 02/06/2001 | US6183784 A plurality of cell growth stimulating factors, extracted from milk product, in concentrated form. cell culture compositions and pharmaceutical or veterinary compositions including the above milk product extract. |
| 02/06/2001 | US6183781 Implantable polymer/drug matrix mass; fragmenting a solid polymer/drug matrix at a temperature below the glass transition temperature of the solid polymer/drug matrix; compressing the polymer/drug matrix microparticles |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183755 These proteins can be used to produce specific and sensitive diagnostic assay kits. the specific combination of the immunologically active proteins makes precise diagnosis possible. |
| 02/06/2001 | US6183751 Unique associated Kaposi's Sarcoma virus sequences and uses thereof |
| 02/06/2001 | US6183750 Vaccines; gene expression |
| 02/06/2001 | US6183744 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 02/06/2001 | US6183743 Modified factor VII |
| 02/06/2001 | US6183742 Administering to skin treat alopecia; infectious pancreatic necrosis virus in fish |
| 02/06/2001 | US6183740 Recombinant bacterial phytases and uses thereof |
| 02/06/2001 | US6183738 Modified arginine deiminase |
| 02/06/2001 | US6183734 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 02/06/2001 | US6183723 Orally drug delivering vitamin b12 via a conjugated transcobalamin ii-cobalamin complex to a patient |
| 02/06/2001 | US6183721 A radioactive cyclic octapeptides for radiotherapy of somatostatin receptor positive tumors; antitumor agents |
| 02/06/2001 | US6183692 Blood collection device, an affinity cartridge having solid support and molecule with affinity for plasminogen, syringe with buffer and release agent for plasminogen, sterilizing filter and compound for converting plasminogen into plasmin |
| 02/06/2001 | US6182898 Bar code scanner with intuitive head aiming and collimated scan volume |
| 02/06/2001 | CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography |
| 02/06/2001 | CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 02/06/2001 | CA2213798C Method for stimulating an immune response |
| 02/06/2001 | CA2163032C Antibody fragments in therapy |